data_1n3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n3j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.2 139.38 3.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.0 146.94 37.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.325 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.21 -27.76 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.788 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' CG1' ' A' ' 6' ' ' VAL . 96.5 mtt180 -68.45 -51.88 38.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.419 ' CG1' ' O ' ' A' ' 5' ' ' ARG . 17.4 m -155.25 150.99 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.435 HG23 HD12 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.04 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.774 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.74 138.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 110.7 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.55 91.0 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -110.02 -21.1 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.471 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' N ' ' HG3' ' A' ' 10' ' ' LYS . 2.5 m -77.02 132.26 71.29 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.413 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.76 131.18 36.92 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.466 1.245 . . . . 0.0 111.453 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 11' ' ' SER . 3.3 pp -175.23 33.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 110.282 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 50.78 20.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.78 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.17 124.63 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 110.165 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.437 ' CA ' HG22 ' A' ' 67' ' ' ILE . . . 162.93 171.1 28.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 101' ' ' ILE . 2.1 p -110.81 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -1.19 . . . . 0.0 109.039 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.485 ' CE1' ' HB3' ' A' ' 100' ' ' GLU . 1.6 m-85 -88.0 158.96 18.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 111.648 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' CB ' HD11 ' A' ' 101' ' ' ILE . . . -124.84 133.54 53.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.753 -0.592 . . . . 0.0 110.012 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.24 70.21 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.432 ' N ' ' HA ' ' A' ' 97' ' ' ILE . 15.2 ptmt -173.39 89.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -0.96 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.5 p -51.42 145.93 7.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.75 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CG ' ' O ' ' A' ' 23' ' ' SER . 1.6 m-85 -170.32 177.72 4.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.92 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.48 106.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.55 42.36 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.22 -178.21 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -1.207 . . . . 0.0 110.258 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.43 ' HB3' ' CD1' ' A' ' 116' ' ' LEU . 2.9 tt -140.71 126.42 19.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.682 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 ' HB ' ' CG2' ' A' ' 89' ' ' ILE . 39.7 t -114.39 168.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.87 150.25 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.823 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.92 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 110.095 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.82 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 110.644 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.85 51.69 0.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.468 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.36 143.37 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.985 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.528 HD11 ' CD1' ' B' ' 36' ' ' ILE 0.271 97.7 mt -132.44 89.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' CG2' ' CB ' ' A' ' 59' ' ' ALA . 61.7 t -109.21 147.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.484 -0.76 . . . . 0.0 112.875 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.544 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 25.1 mmm180 -150.21 -160.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 89.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.717 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.92 157.02 1.12 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.161 -0.962 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.66 -46.07 63.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.931 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.02 -24.76 4.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.55 ' CE2' ' CD1' ' A' ' 47' ' ' LEU . 0.8 OUTLIER -63.23 -60.98 2.68 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.539 -0.726 . . . . 0.0 109.793 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.61 -28.86 5.33 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.16 -21.2 22.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -1.144 . . . . 0.0 110.5 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' CZ3' ' B' ' 43' ' ' TRP . . . -91.68 -48.23 6.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.459 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 60' ' ' MET . 0.5 OUTLIER -86.66 21.28 2.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 111.579 -177.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.19 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.965 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 47' ' ' LEU . 1.3 m-20 -149.5 -107.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 12.3 m-85 -104.29 65.98 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.3 -1.5 . . . . 0.0 107.399 175.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 0.5 OUTLIER -56.29 140.92 43.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.108 0.956 . . . . 0.0 112.422 -174.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -142.98 94.66 2.66 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 t -119.98 153.67 35.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.011 -1.056 . . . . 0.0 111.118 -176.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -143.26 109.82 5.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.883 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.776 -0.577 . . . . 0.0 111.082 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' ARG . 15.3 p-10 -116.94 -32.66 5.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.856 -1.152 . . . . 0.0 110.819 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.86 125.26 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.806 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 9.7 m -126.17 105.82 9.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 109.246 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' CB ' ' CG2' ' A' ' 37' ' ' VAL . . . -133.98 -176.84 4.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.062 -1.023 . . . . 0.0 111.349 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.562 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 2.2 ptm -149.87 153.3 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.476 ' O ' ' CD1' ' A' ' 50' ' ' TYR . . . -129.67 -163.31 1.29 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 109.883 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.448 HD12 ' CD2' ' B' ' 62' ' ' LEU . 0.4 OUTLIER -172.52 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.28 3.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.533 ' CD1' ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -99.15 -20.9 16.41 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.683 -0.892 . . . . 0.0 109.653 177.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.38 -47.48 82.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.0 79.45 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -1.09 . . . . 0.0 109.295 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.437 HG22 ' CA ' ' A' ' 17' ' ' GLY . 75.3 mt -63.75 -23.58 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 64' ' ' PHE . 24.2 m-85 -90.72 -21.51 21.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.3 t-20 -51.49 -55.06 21.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 110.524 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.54 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 69' ' ' ASN . 78.8 p -151.64 91.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.308 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -20.92 60.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HB2' ' CD1' ' A' ' 105' ' ' TYR . 29.5 Cg_endo -67.52 96.21 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.343 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.94 -43.14 68.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.541 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.57 162.42 27.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 0.0 110.758 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.38 169.46 10.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 103' ' ' ILE . 30.2 p-80 -147.69 158.67 44.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.108 -0.995 . . . . 0.0 111.001 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.8 88.47 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.779 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' A' ' 81' ' ' THR . 1.6 mp -128.08 92.45 3.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.054 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -164.29 -170.44 2.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.297 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 -24.07 6.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.12 -95.26 0.65 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.84 -164.47 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -1.136 . . . . 0.0 110.111 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' CE ' HG13 ' A' ' 37' ' ' VAL . 14.9 mmtt 60.91 -127.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.58 -151.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.525 -1.36 . . . . 0.0 110.58 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 9.0 tpt -132.24 44.37 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.79 166.43 29.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 110.321 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.435 ' CG2' ' HB ' ' A' ' 30' ' ' VAL . 4.9 mt -128.8 144.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -121.95 143.56 49.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.4 m -115.53 99.34 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.238 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.412 ' N ' ' CD1' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -69.59 -5.97 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.247 -0.908 . . . . 0.0 110.978 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.401 ' N ' HD11 ' A' ' 92' ' ' ILE . 52.5 mttt -111.76 138.81 21.69 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.845 -1.16 . . . . 0.0 110.296 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -51.54 143.88 34.59 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.567 1.298 . . . . 0.0 110.708 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -90.37 156.03 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 110.108 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.44 ' O ' ' CG2' ' A' ' 97' ' ' ILE . . . -122.35 47.41 1.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.942 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 96' ' ' ALA . 18.8 tt 39.48 34.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.411 0.624 . . . . 0.0 111.775 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.82 43.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 100' ' ' GLU . 28.1 tt0 -106.23 167.83 9.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -1.061 . . . . 0.0 110.055 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.485 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 13.1 pt-20 -98.09 151.86 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.432 HD11 ' CB ' ' A' ' 20' ' ' ALA . 57.5 mt -126.94 154.31 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.22 -0.925 . . . . 0.0 110.719 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.428 ' O ' ' CG2' ' A' ' 103' ' ' ILE . 68.6 p -137.92 -145.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.496 HG12 ' CG ' ' A' ' 68' ' ' PHE . 1.1 pt -154.1 -165.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.949 -1.094 . . . . 0.0 110.979 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.58 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.72 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 74' ' ' PRO . 13.6 t80 -160.99 67.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.827 . . . . 0.0 109.992 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.02 -129.44 49.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' OD1' ' CD2' ' A' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -1.167 . . . . 0.0 110.316 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t0 51.57 68.71 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.522 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' OD1' ' A' ' 107' ' ' ASP . 24.0 m-85 -59.13 107.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.01 173.01 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.478 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 1.8 pt? -152.82 -162.01 1.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.2 p -174.3 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 110.545 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.44 85.28 0.19 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.301 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -62.17 147.43 95.06 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.674 1.355 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.69 1.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.43 ' CD1' ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -75.12 76.65 2.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.222 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 119' ' ' ASN . 41.3 p -58.52 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER 57.64 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 110.642 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.198 0.523 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -167.25 139.37 3.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -140.91 146.99 38.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.3 -27.68 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 110.79 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.413 ' O ' ' CG1' ' B' ' 6' ' ' VAL . 96.5 mtt180 -68.47 -51.9 38.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.119 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . 0.413 ' CG1' ' O ' ' B' ' 5' ' ' ARG . 17.4 m -155.24 151.02 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.228 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ILE . . . . . 0.449 HD12 HG23 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.0 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' VAL . . . . . . . . . . . . . 97.5 t -91.71 138.02 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.673 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.47 90.91 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' B' ' 67' ' ' ILE . 0.1 OUTLIER -109.93 -21.07 12.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.384 -0.823 . . . . 0.0 110.494 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' B' ' 13' ' ' LEU . 2.5 m -76.98 132.26 71.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.393 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 131.31 37.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.455 1.239 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.419 ' CD2' ' O ' ' B' ' 11' ' ' SER . 3.3 pp -175.4 33.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 110.21 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.16 50.78 20.89 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.21 124.62 43.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -1.121 . . . . 0.0 110.121 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.444 ' CA ' HG22 ' B' ' 67' ' ' ILE . . . 162.9 171.07 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.409 HG11 ' HB ' ' B' ' 101' ' ' ILE . 2.1 p -110.76 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.077 -1.249 . . . . 0.0 109.229 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.475 ' CE1' ' HB3' ' B' ' 100' ' ' GLU . 1.7 m-85 -87.05 159.05 19.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 111.837 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.427 ' CB ' HD11 ' B' ' 101' ' ' ILE . . . -124.95 133.62 52.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 110.028 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.26 70.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LYS . . . . . 0.431 ' N ' ' HA ' ' B' ' 97' ' ' ILE . 15.3 ptmt -173.44 89.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' B' ' 24' ' ' PHE . 26.6 p -51.33 145.84 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.98 . . . . 0.0 110.776 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' B' ' 23' ' ' SER . 1.6 m-85 -170.34 177.69 4.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.86 11.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.37 106.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.436 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.58 42.33 0.07 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 -178.23 4.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -1.181 . . . . 0.0 110.235 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LEU . . . . . 0.431 ' HB3' ' CD1' ' B' ' 116' ' ' LEU . 2.9 tt -140.73 126.43 19.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.69 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.431 ' HB ' ' CG2' ' B' ' 89' ' ' ILE . 39.6 t -114.4 168.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -136.87 150.22 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.004 -1.06 . . . . 0.0 110.859 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.9 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -174.83 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 110.626 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 51.7 0.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.27 143.37 28.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.528 ' CD1' HD11 ' A' ' 36' ' ' ILE 0.27 96.4 mt -132.42 89.39 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' VAL . . . . . 0.462 ' CG2' ' CB ' ' B' ' 59' ' ' ALA . 61.5 t -109.23 147.65 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.668 0.747 . . . . 0.0 112.853 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.549 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 25.2 mmm180 -150.37 -160.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.06 88.99 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 110.676 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.87 156.99 1.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.186 -0.946 . . . . 0.0 110.6 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.67 -46.07 63.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.862 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.07 -24.75 4.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.549 ' CD1' ' HB2' ' B' ' 38' ' ' ARG . 0.8 OUTLIER -63.13 -60.97 2.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.568 -0.707 . . . . 0.0 109.785 178.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.62 -28.71 5.26 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.59 -20.63 22.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 110.419 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 43' ' ' TRP . . . -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.565 ' HG ' ' HB3' ' B' ' 60' ' ' MET . 0.5 OUTLIER -86.92 21.4 2.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.112 -0.992 . . . . 0.0 111.551 -177.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.13 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.82 . . . . 0.0 111.973 -178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.3 m-20 -149.39 -107.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 12.5 m-85 -104.33 65.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.327 -1.483 . . . . 0.0 107.414 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.502 ' CD1' ' HG ' ' B' ' 47' ' ' LEU . 0.4 OUTLIER -56.21 140.9 43.02 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.024 0.916 . . . . 0.0 112.442 -174.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -143.04 94.58 2.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 16.9 t -119.89 153.67 35.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.068 -1.02 . . . . 0.0 111.196 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -143.22 109.8 5.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.438 -0.789 . . . . 0.0 109.927 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.828 -0.545 . . . . 0.0 111.054 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 54' ' ' ARG . 15.3 p-10 -116.89 -32.67 5.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.842 -1.161 . . . . 0.0 110.824 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.98 125.2 23.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.786 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 10.6 m -126.08 105.72 9.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.023 . . . . 0.0 109.386 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ALA . . . . . 0.462 ' CB ' ' CG2' ' B' ' 37' ' ' VAL . . . -134.04 -176.77 4.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.035 -1.041 . . . . 0.0 111.455 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' MET . . . . . 0.565 ' HB3' ' HG ' ' B' ' 47' ' ' LEU . 2.2 ptm -150.11 153.49 36.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.726 -0.609 . . . . 0.0 109.448 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ALA . . . . . 0.458 ' O ' ' CD1' ' B' ' 50' ' ' TYR . . . -129.77 -163.27 1.28 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.448 ' CD2' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -172.54 61.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.12 -33.31 3.07 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' PHE . . . . . 0.535 ' CD1' ' CZ ' ' B' ' 68' ' ' PHE . 0.1 OUTLIER -99.11 -20.92 16.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.664 -0.904 . . . . 0.0 109.7 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.46 -47.41 83.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.9 79.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.379 -1.071 . . . . 0.0 109.243 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.444 HG22 ' CA ' ' B' ' 17' ' ' GLY . 75.4 mt -63.98 -23.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.499 -0.751 . . . . 0.0 109.704 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' B' ' 64' ' ' PHE . 24.2 m-85 -90.95 -21.46 21.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 110.151 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 71' ' ' SER . 17.4 t-20 -51.54 -55.0 21.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.535 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.59 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 69' ' ' ASN . 78.8 p -151.67 90.98 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -20.96 60.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PRO . . . . . 0.481 ' HB2' ' CD1' ' B' ' 105' ' ' TYR . 29.6 Cg_endo -67.53 96.23 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.675 1.355 . . . . 0.0 110.367 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.86 -43.22 68.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' ALA . . . . . . . . . . . . . . . -162.55 162.47 27.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 110.762 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -92.4 169.57 10.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.087 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . 0.475 ' CE1' ' HB ' ' B' ' 103' ' ' ILE . 30.0 p-80 -147.76 158.86 44.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 110.94 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -151.07 88.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' LEU . . . . . 0.424 ' O ' ' CG2' ' B' ' 81' ' ' THR . 1.6 mp -128.18 92.42 3.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.982 -1.074 . . . . 0.0 111.037 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' THR . . . . . 0.424 ' CG2' ' O ' ' B' ' 80' ' ' LEU . 0.8 OUTLIER -164.28 -170.44 2.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 110.281 179.037 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.44 -24.11 6.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.487 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.04 -95.25 0.65 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.99 -164.27 1.13 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.234 -1.156 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LYS . . . . . 0.434 ' CE ' HG13 ' B' ' 37' ' ' VAL . 15.1 mmtt 60.78 -127.25 0.94 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.449 -1.407 . . . . 0.0 110.608 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' MET . . . . . . . . . . . . . 9.0 tpt -132.26 44.49 2.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.99 166.31 30.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.431 ' CG2' ' HB ' ' B' ' 30' ' ' VAL . 4.9 mt -128.73 144.18 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.859 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -121.98 143.53 49.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 60.0 m -115.54 99.32 7.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.407 ' CD1' ' N ' ' B' ' 92' ' ' ILE . 0.1 OUTLIER -69.55 -5.99 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.259 -0.901 . . . . 0.0 110.946 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LYS . . . . . . . . . . . . . 52.5 mttt -111.74 138.75 21.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.752 -1.218 . . . . 0.0 110.283 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.68 143.94 35.69 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.559 1.294 . . . . 0.0 110.718 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 47.7 mm -90.31 156.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.159 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ALA . . . . . 0.436 ' O ' ' CG2' ' B' ' 97' ' ' ILE . . . -122.34 47.35 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.917 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' ILE . . . . . 0.436 ' CG2' ' O ' ' B' ' 96' ' ' ALA . 18.9 tt 39.49 34.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.368 0.604 . . . . 0.0 111.795 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.87 43.26 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' B' ' 100' ' ' GLU . 28.1 tt0 -106.27 167.88 9.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -1.102 . . . . 0.0 109.992 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' GLU . . . . . 0.475 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 13.1 pt-20 -98.13 151.7 20.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.438 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ILE . . . . . 0.427 HD11 ' CB ' ' B' ' 20' ' ' ALA . 57.6 mt -126.59 154.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -0.881 . . . . 0.0 110.942 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' THR . . . . . 0.421 ' O ' ' CG2' ' B' ' 103' ' ' ILE . 69.2 p -137.99 -145.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.762 -0.587 . . . . 0.0 109.523 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' ILE . . . . . 0.493 HG12 ' CG ' ' B' ' 68' ' ' PHE . 1.1 pt -154.11 -165.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.987 -1.07 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.55 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.475 -0.765 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' B' ' 74' ' ' PRO . 13.7 t80 -161.01 67.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.99 -129.43 49.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' B' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.319 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 17.1 t0 51.61 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.558 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' B' ' 107' ' ' ASP . 24.2 m-85 -59.2 107.91 0.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.302 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.05 173.07 3.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 110.466 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . 0.481 ' CD2' ' N ' ' B' ' 111' ' ' LEU . 1.8 pt? -152.92 -162.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.4 p -174.24 31.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.565 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.39 85.3 0.19 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -62.2 147.36 95.16 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.628 1.33 . . . . 0.0 110.472 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.77 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 110.492 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' B' ' 29' ' ' LEU . 0.3 OUTLIER -75.22 76.75 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 110.181 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' THR . . . . . 0.44 ' O ' ' N ' ' B' ' 119' ' ' ASN . 41.3 p -58.57 87.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.444 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' B' ' 116' ' ' LEU . 0.7 OUTLIER 57.77 -83.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.502 -0.749 . . . . 0.0 110.627 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.295 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.2 139.38 3.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.0 146.94 37.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.325 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.21 -27.76 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.788 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 6' ' ' VAL . 96.5 mtt180 -68.45 -51.88 38.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG21 HG13 ' A' ' 30' ' ' VAL . 17.4 m -155.25 150.99 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.593 HD13 ' C ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.04 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.774 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' HD13 ' A' ' 7' ' ' ILE . 97.0 t -91.74 138.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 110.7 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.55 91.0 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.836 ' CB ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -110.02 -21.1 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.471 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.688 ' O ' HD23 ' A' ' 13' ' ' LEU . 2.5 m -77.02 132.26 71.29 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.413 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.76 131.18 36.92 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.466 1.245 . . . . 0.0 111.453 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.3 pp -175.23 33.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 110.282 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 50.78 20.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.78 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.17 124.63 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 110.165 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' CA ' HG23 ' A' ' 67' ' ' ILE . . . 162.93 171.1 28.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -110.81 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -1.19 . . . . 0.0 109.039 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' GLU . 1.6 m-85 -88.0 158.96 18.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 111.648 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.051 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.84 133.54 53.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.753 -0.592 . . . . 0.0 110.012 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.24 70.21 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' N ' ' HA ' ' A' ' 97' ' ' ILE . 15.2 ptmt -173.39 89.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -0.96 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.5 p -51.42 145.93 7.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.75 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CG ' ' O ' ' A' ' 23' ' ' SER . 1.6 m-85 -170.32 177.72 4.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.92 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -53.48 106.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.55 42.36 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.22 -178.21 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -1.207 . . . . 0.0 110.258 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 116' ' ' LEU . 2.9 tt -140.71 126.42 19.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.682 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.684 ' N ' HD23 ' A' ' 29' ' ' LEU . 39.7 t -114.39 168.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -136.87 150.25 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.823 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.92 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 110.095 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -174.82 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 110.644 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -150.85 51.69 0.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.468 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.36 143.37 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.985 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' B' ' 36' ' ' ILE 0.271 97.7 mt -132.44 89.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.976 HG22 ' CB ' ' A' ' 59' ' ' ALA . 61.7 t -109.21 147.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.484 -0.76 . . . . 0.0 112.875 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 25.1 mmm180 -150.21 -160.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 89.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.717 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.92 157.02 1.12 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.161 -0.962 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.66 -46.07 63.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.931 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.02 -24.76 4.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.893 ' CE2' HD13 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -63.23 -60.98 2.68 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.539 -0.726 . . . . 0.0 109.793 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.61 -28.86 5.33 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.16 -21.2 22.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -1.144 . . . . 0.0 110.5 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' CZ3' ' B' ' 43' ' ' TRP . . . -91.68 -48.23 6.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.459 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.893 HD13 ' CE2' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -86.66 21.28 2.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 111.579 -177.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -44.19 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.965 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' B' ' 81' ' ' THR . 1.3 m-20 -149.5 -107.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 12.3 m-85 -104.29 65.98 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.3 -1.5 . . . . 0.0 107.399 175.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.614 HD22 ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -56.29 140.92 43.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.108 0.956 . . . . 0.0 112.422 -174.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -142.98 94.66 2.66 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' MET . 16.8 t -119.98 153.67 35.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.011 -1.056 . . . . 0.0 111.118 -176.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -143.26 109.82 5.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.883 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.776 -0.577 . . . . 0.0 111.082 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' ARG . 15.3 p-10 -116.94 -32.66 5.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.856 -1.152 . . . . 0.0 110.819 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' SER . 27.3 mmm -63.86 125.26 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.806 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 9.7 m -126.17 105.82 9.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 109.246 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.976 ' CB ' HG22 ' A' ' 37' ' ' VAL . . . -133.98 -176.84 4.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.062 -1.023 . . . . 0.0 111.349 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.614 ' HG2' HD12 ' A' ' 47' ' ' LEU . 2.2 ptm -149.87 153.3 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' C ' HD23 ' A' ' 62' ' ' LEU . . . -129.67 -163.31 1.29 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 109.883 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.002 HD11 HD11 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -172.52 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.28 3.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.799 ' HA ' HD12 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -99.15 -20.9 16.41 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.683 -0.892 . . . . 0.0 109.653 177.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.38 -47.48 82.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.0 79.45 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -1.09 . . . . 0.0 109.295 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.836 HD11 ' CB ' ' A' ' 10' ' ' LYS . 75.3 mt -63.75 -23.58 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 64' ' ' PHE . 24.2 m-85 -90.72 -21.51 21.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.3 t-20 -51.49 -55.06 21.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 110.524 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.54 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 69' ' ' ASN . 78.8 p -151.64 91.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.308 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -20.92 60.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HB2' ' CD1' ' A' ' 105' ' ' TYR . 29.5 Cg_endo -67.52 96.21 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.343 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.94 -43.14 68.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.541 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -162.57 162.42 27.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 0.0 110.758 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -92.38 169.46 10.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 103' ' ' ILE . 30.2 p-80 -147.69 158.67 44.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.108 -0.995 . . . . 0.0 111.001 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.8 88.47 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.779 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.768 ' O ' HG23 ' A' ' 81' ' ' THR . 1.6 mp -128.08 92.45 3.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.054 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -164.29 -170.44 2.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.297 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 -24.07 6.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.12 -95.26 0.65 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.84 -164.47 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -1.136 . . . . 0.0 110.111 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 81' ' ' THR . 14.9 mmtt 60.91 -127.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.58 -151.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.525 -1.36 . . . . 0.0 110.58 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.645 ' CE ' HD23 ' A' ' 80' ' ' LEU . 9.0 tpt -132.24 44.37 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.79 166.43 29.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 110.321 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.757 HD11 HD21 ' A' ' 80' ' ' LEU . 4.9 mt -128.8 144.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 t80 -121.95 143.56 49.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 1.056 HG21 HD11 ' A' ' 95' ' ' ILE . 60.4 m -115.53 99.34 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.238 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.465 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.1 OUTLIER -69.59 -5.97 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.247 -0.908 . . . . 0.0 110.978 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 91' ' ' THR . 52.5 mttt -111.76 138.81 21.69 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.845 -1.16 . . . . 0.0 110.296 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -51.54 143.88 34.59 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.567 1.298 . . . . 0.0 110.708 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 91' ' ' THR . 47.7 mm -90.37 156.03 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 110.108 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 97' ' ' ILE . . . -122.35 47.41 1.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.942 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 96' ' ' ALA . 18.8 tt 39.48 34.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.411 0.624 . . . . 0.0 111.775 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.82 43.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 100' ' ' GLU . 28.1 tt0 -106.23 167.83 9.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -1.061 . . . . 0.0 110.055 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 13.1 pt-20 -98.09 151.86 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -126.94 154.31 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.22 -0.925 . . . . 0.0 110.719 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 103' ' ' ILE . 68.6 p -137.92 -145.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.546 HG23 ' C ' ' A' ' 102' ' ' THR . 1.1 pt -154.1 -165.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.949 -1.094 . . . . 0.0 110.979 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.58 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.72 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.503 ' CD1' ' HB2' ' A' ' 74' ' ' PRO . 13.6 t80 -160.99 67.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.827 . . . . 0.0 109.992 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.02 -129.44 49.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' OD1' ' CD2' ' A' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -1.167 . . . . 0.0 110.316 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t0 51.57 68.71 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.522 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' OD1' ' A' ' 107' ' ' ASP . 24.0 m-85 -59.13 107.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.01 173.01 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.729 ' N ' HD23 ' A' ' 111' ' ' LEU . 1.8 pt? -152.82 -162.01 1.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.2 p -174.3 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 110.545 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.44 85.28 0.19 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.301 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -62.17 147.43 95.06 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.674 1.355 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.69 1.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -75.12 76.65 2.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.222 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 119' ' ' ASN . 41.3 p -58.52 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER 57.64 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 110.642 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.198 0.523 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -167.25 139.37 3.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -140.91 146.99 38.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.3 -27.68 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 110.79 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.488 ' O ' HG13 ' B' ' 6' ' ' VAL . 96.5 mtt180 -68.47 -51.9 38.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.119 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.625 HG21 HG13 ' B' ' 30' ' ' VAL . 17.4 m -155.24 151.02 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.228 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ILE . . . . . 0.592 HD13 ' C ' ' B' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.0 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' VAL . . . . . 0.537 ' N ' HD13 ' B' ' 7' ' ' ILE . 97.5 t -91.71 138.02 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.673 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.47 90.91 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.829 ' CB ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -109.93 -21.07 12.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.384 -0.823 . . . . 0.0 110.494 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.679 ' O ' HD23 ' B' ' 13' ' ' LEU . 2.5 m -76.98 132.26 71.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.393 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 131.31 37.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.455 1.239 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.779 ' O ' HD12 ' B' ' 13' ' ' LEU . 3.3 pp -175.4 33.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 110.21 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.16 50.78 20.89 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.21 124.62 43.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -1.121 . . . . 0.0 110.121 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.621 ' CA ' HG23 ' B' ' 67' ' ' ILE . . . 162.9 171.07 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.1 p -110.76 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.077 -1.249 . . . . 0.0 109.229 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' B' ' 100' ' ' GLU . 1.7 m-85 -87.05 159.05 19.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 111.837 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 1.078 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.95 133.62 52.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 110.028 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.26 70.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LYS . . . . . 0.444 ' N ' ' HA ' ' B' ' 97' ' ' ILE . 15.3 ptmt -173.44 89.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' B' ' 24' ' ' PHE . 26.6 p -51.33 145.84 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.98 . . . . 0.0 110.776 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' B' ' 23' ' ' SER . 1.6 m-85 -170.34 177.69 4.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.86 11.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 92' ' ' ILE . 0.1 OUTLIER -53.37 106.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.436 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.58 42.33 0.07 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 -178.23 4.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -1.181 . . . . 0.0 110.235 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LEU . . . . . 0.819 ' HB3' HD12 ' B' ' 116' ' ' LEU . 2.9 tt -140.73 126.43 19.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.69 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.674 ' N ' HD23 ' B' ' 29' ' ' LEU . 39.6 t -114.4 168.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLU . . . . . 0.505 ' HA ' HD12 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -136.87 150.22 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.004 -1.06 . . . . 0.0 110.859 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.9 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.474 ' C ' HD12 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -174.83 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 110.626 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.474 HD12 ' C ' ' B' ' 33' ' ' CYS . 0.6 OUTLIER -150.88 51.7 0.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.27 143.37 28.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.956 HD11 HD22 ' A' ' 62' ' ' LEU 0.27 96.4 mt -132.42 89.39 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' VAL . . . . . 0.957 HG22 ' CB ' ' B' ' 59' ' ' ALA . 61.5 t -109.23 147.65 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.668 0.747 . . . . 0.0 112.853 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.563 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 25.2 mmm180 -150.37 -160.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.06 88.99 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 110.676 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.87 156.99 1.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.186 -0.946 . . . . 0.0 110.6 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.67 -46.07 63.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.862 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.07 -24.75 4.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.899 ' CE2' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -63.13 -60.97 2.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.568 -0.707 . . . . 0.0 109.785 178.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.62 -28.71 5.26 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.59 -20.63 22.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 110.419 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 43' ' ' TRP . . . -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -86.92 21.4 2.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.112 -0.992 . . . . 0.0 111.551 -177.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . 0.587 ' HA ' HD21 ' B' ' 51' ' ' LEU . 0.6 OUTLIER -44.13 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.82 . . . . 0.0 111.973 -178.33 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.3 m-20 -149.39 -107.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' B' ' 50' ' ' TYR . 12.5 m-85 -104.33 65.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.327 -1.483 . . . . 0.0 107.414 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.632 HD22 ' H ' ' B' ' 51' ' ' LEU . 0.4 OUTLIER -56.21 140.9 43.02 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.024 0.916 . . . . 0.0 112.442 -174.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -143.04 94.58 2.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 16.9 t -119.89 153.67 35.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.068 -1.02 . . . . 0.0 111.196 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -143.22 109.8 5.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.438 -0.789 . . . . 0.0 109.927 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.828 -0.545 . . . . 0.0 111.054 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 54' ' ' ARG . 15.3 p-10 -116.89 -32.67 5.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.842 -1.161 . . . . 0.0 110.824 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.98 125.2 23.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.786 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 10.6 m -126.08 105.72 9.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.023 . . . . 0.0 109.386 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' B' ' 37' ' ' VAL . . . -134.04 -176.77 4.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.035 -1.041 . . . . 0.0 111.455 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' MET . . . . . 0.628 ' HG2' HD12 ' B' ' 47' ' ' LEU . 2.2 ptm -150.11 153.49 36.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.726 -0.609 . . . . 0.0 109.448 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ALA . . . . . 0.542 ' C ' HD23 ' B' ' 62' ' ' LEU . . . -129.77 -163.27 1.28 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -172.54 61.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.12 -33.31 3.07 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -99.11 -20.92 16.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.664 -0.904 . . . . 0.0 109.7 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.46 -47.41 83.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.9 79.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.379 -1.071 . . . . 0.0 109.243 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 10' ' ' LYS . 75.4 mt -63.98 -23.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.499 -0.751 . . . . 0.0 109.704 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' B' ' 64' ' ' PHE . 24.2 m-85 -90.95 -21.46 21.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 110.151 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 71' ' ' SER . 17.4 t-20 -51.54 -55.0 21.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.535 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.59 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 69' ' ' ASN . 78.8 p -151.67 90.98 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -20.96 60.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' B' ' 105' ' ' TYR . 29.6 Cg_endo -67.53 96.23 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.675 1.355 . . . . 0.0 110.367 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.86 -43.22 68.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -162.55 162.47 27.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 110.762 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ARG . . . . . 0.511 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.7 OUTLIER -92.4 169.57 10.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.087 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 78' ' ' HIS . . . . . 0.486 ' CE1' ' HB ' ' B' ' 103' ' ' ILE . 30.0 p-80 -147.76 158.86 44.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 110.94 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -151.07 88.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 89' ' ' ILE . 1.6 mp -128.18 92.42 3.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.982 -1.074 . . . . 0.0 111.037 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' THR . . . . . 0.771 HG23 ' O ' ' B' ' 80' ' ' LEU . 0.8 OUTLIER -164.28 -170.44 2.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 110.281 179.037 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.44 -24.11 6.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.487 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.04 -95.25 0.65 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.99 -164.27 1.13 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.234 -1.156 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LYS . . . . . 0.401 ' HB2' ' OG1' ' B' ' 81' ' ' THR . 15.1 mmtt 60.78 -127.25 0.94 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.449 -1.407 . . . . 0.0 110.608 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' MET . . . . . 0.649 ' CE ' HD23 ' B' ' 80' ' ' LEU . 9.0 tpt -132.26 44.49 2.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.99 166.31 30.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.772 HD11 HD21 ' B' ' 80' ' ' LEU . 4.9 mt -128.73 144.18 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.859 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' PHE . . . . . 0.515 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 2.1 t80 -121.98 143.53 49.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . 1.082 HG21 HD11 ' B' ' 95' ' ' ILE . 60.0 m -115.54 99.32 7.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.476 ' N ' HD13 ' B' ' 92' ' ' ILE . 0.1 OUTLIER -69.55 -5.99 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.259 -0.901 . . . . 0.0 110.946 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LYS . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' THR . 52.5 mttt -111.74 138.75 21.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.752 -1.218 . . . . 0.0 110.283 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.68 143.94 35.69 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.559 1.294 . . . . 0.0 110.718 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . 1.082 HD11 HG21 ' B' ' 91' ' ' THR . 47.7 mm -90.31 156.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.159 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 97' ' ' ILE . . . -122.34 47.35 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.917 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 96' ' ' ALA . 18.9 tt 39.49 34.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.368 0.604 . . . . 0.0 111.795 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.87 43.26 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' B' ' 100' ' ' GLU . 28.1 tt0 -106.27 167.88 9.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -1.102 . . . . 0.0 109.992 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 13.1 pt-20 -98.13 151.7 20.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.438 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ILE . . . . . 1.078 HD11 ' HB2' ' B' ' 20' ' ' ALA . 57.6 mt -126.59 154.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -0.881 . . . . 0.0 110.942 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' THR . . . . . 0.547 ' C ' HG23 ' B' ' 103' ' ' ILE . 69.2 p -137.99 -145.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.762 -0.587 . . . . 0.0 109.523 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' ILE . . . . . 0.547 HG23 ' C ' ' B' ' 102' ' ' THR . 1.1 pt -154.11 -165.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.987 -1.07 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.55 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.475 -0.765 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' B' ' 74' ' ' PRO . 13.7 t80 -161.01 67.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.99 -129.43 49.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' B' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.319 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 17.1 t0 51.61 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.558 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' B' ' 107' ' ' ASP . 24.2 m-85 -59.2 107.91 0.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.302 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.05 173.07 3.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 110.466 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . 0.734 ' N ' HD23 ' B' ' 111' ' ' LEU . 1.8 pt? -152.92 -162.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.4 p -174.24 31.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.565 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.39 85.3 0.19 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -62.2 147.36 95.16 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.628 1.33 . . . . 0.0 110.472 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.77 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 110.492 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.819 HD12 ' HB3' ' B' ' 29' ' ' LEU . 0.3 OUTLIER -75.22 76.75 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 110.181 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 117' ' ' THR . . . . . 0.44 ' O ' ' N ' ' B' ' 119' ' ' ASN . 41.3 p -58.57 87.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.444 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' B' ' 116' ' ' LEU . 0.7 OUTLIER 57.77 -83.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.502 -0.749 . . . . 0.0 110.627 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.295 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -167.2 139.38 3.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -141.0 146.94 37.92 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.913 . . . . 0.0 110.325 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.21 -27.76 2.62 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.291 -0.881 . . . . 0.0 110.788 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' HG13 ' A' ' 6' ' ' VAL . 96.5 mtt180 -68.45 -51.88 38.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 110.118 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.613 HG21 HG13 ' A' ' 30' ' ' VAL . 17.4 m -155.25 150.99 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -0.878 . . . . 0.0 110.24 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.593 ' C ' HD13 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.04 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.232 -0.918 . . . . 0.0 109.774 179.424 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' N ' HD13 ' A' ' 7' ' ' ILE . 97.0 t -91.74 138.03 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 110.7 -179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.55 91.0 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.836 ' CB ' HD11 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -110.02 -21.1 12.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 110.471 -179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.688 ' O ' HD23 ' A' ' 13' ' ' LEU . 2.5 m -77.02 132.26 71.29 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.152 -0.968 . . . . 0.0 110.413 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -51.76 131.18 36.92 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 O-C-N 123.466 1.245 . . . . 0.0 111.453 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 13' ' ' LEU . 3.3 pp -175.23 33.21 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.452 -0.78 . . . . 0.0 110.282 177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 50.78 20.63 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.78 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.17 124.63 43.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -1.124 . . . . 0.0 110.165 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.617 ' CA ' HG23 ' A' ' 67' ' ' ILE . . . 162.93 171.1 28.74 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.771 HG13 ' HB ' ' A' ' 101' ' ' ILE . 2.1 p -110.81 108.7 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -1.19 . . . . 0.0 109.039 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.506 ' CE1' ' HB3' ' A' ' 100' ' ' GLU . 1.6 m-85 -88.0 158.96 18.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.312 -0.867 . . . . 0.0 111.648 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.051 ' HB2' HD11 ' A' ' 101' ' ' ILE . . . -124.84 133.54 53.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.753 -0.592 . . . . 0.0 110.012 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.24 70.21 0.71 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.452 ' N ' ' HA ' ' A' ' 97' ' ' ILE . 15.2 ptmt -173.39 89.7 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.164 -0.96 . . . . 0.0 110.561 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.446 ' O ' ' CG ' ' A' ' 24' ' ' PHE . 26.5 p -51.42 145.93 7.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.17 -0.956 . . . . 0.0 110.75 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' CG ' ' O ' ' A' ' 23' ' ' SER . 1.6 m-85 -170.32 177.72 4.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.791 . . . . 0.0 110.223 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.92 11.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.2 -0.938 . . . . 0.0 110.235 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -53.48 106.27 0.17 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.335 -0.853 . . . . 0.0 110.421 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.55 42.36 0.07 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 91' ' ' THR . 0.3 OUTLIER -92.22 -178.21 4.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -1.207 . . . . 0.0 110.258 179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.803 ' HB3' HD12 ' A' ' 116' ' ' LEU . 2.9 tt -140.71 126.42 19.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.2 -0.938 . . . . 0.0 110.682 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.684 ' N ' HD23 ' A' ' 29' ' ' LEU . 39.7 t -114.39 168.66 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.794 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.501 ' HA ' HD12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER -136.87 150.25 48.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.953 -1.092 . . . . 0.0 110.823 -179.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.92 0.55 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.363 -0.835 . . . . 0.0 110.095 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' C ' HD12 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -174.82 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.058 -1.026 . . . . 0.0 110.644 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.474 HD12 ' C ' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -150.85 51.69 0.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 110.468 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.36 143.37 27.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.985 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' B' ' 36' ' ' ILE 0.271 97.7 mt -132.44 89.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -178.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.976 HG22 ' CB ' ' A' ' 59' ' ' ALA . 61.7 t -109.21 147.61 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.484 -0.76 . . . . 0.0 112.875 -173.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' HB2' ' CD1' ' A' ' 43' ' ' TRP . 25.1 mmm180 -150.21 -160.25 1.14 Allowed 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.08 89.01 1.7 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.037 -1.039 . . . . 0.0 110.717 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.92 157.02 1.12 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.161 -0.962 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.66 -46.07 63.93 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.181 -0.949 . . . . 0.0 109.931 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.02 -24.76 4.01 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.172 -0.955 . . . . 0.0 109.502 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.893 ' CE2' HD13 ' A' ' 47' ' ' LEU . 0.8 OUTLIER -63.23 -60.98 2.68 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.539 -0.726 . . . . 0.0 109.793 178.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.61 -28.86 5.33 Favored Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.16 -21.2 22.32 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -1.144 . . . . 0.0 110.5 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.468 ' O ' ' CZ3' ' B' ' 43' ' ' TRP . . . -91.68 -48.23 6.94 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.197 -0.94 . . . . 0.0 111.459 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.893 HD13 ' CE2' ' A' ' 43' ' ' TRP . 0.5 OUTLIER -86.66 21.28 2.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 111.579 -177.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HA ' HD21 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -44.19 92.56 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.375 -0.828 . . . . 0.0 111.965 -178.198 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' B' ' 81' ' ' THR . 1.3 m-20 -149.5 -107.79 0.07 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 12.3 m-85 -104.29 65.98 0.8 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.3 -1.5 . . . . 0.0 107.399 175.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' H ' HD22 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -56.29 140.92 43.41 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 122.108 0.956 . . . . 0.0 112.422 -174.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -142.98 94.66 2.66 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 57' ' ' MET . 16.8 t -119.98 153.67 35.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.011 -1.056 . . . . 0.0 111.118 -176.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -143.26 109.82 5.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.428 -0.795 . . . . 0.0 109.883 179.26 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.776 -0.577 . . . . 0.0 111.082 -179.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.441 ' N ' ' O ' ' A' ' 54' ' ' ARG . 15.3 p-10 -116.94 -32.66 5.01 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.856 -1.152 . . . . 0.0 110.819 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.4 ' O ' ' HA ' ' A' ' 53' ' ' SER . 27.3 mmm -63.86 125.26 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.954 . . . . 0.0 110.806 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.449 ' O ' ' CD1' ' A' ' 43' ' ' TRP . 9.7 m -126.17 105.82 9.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.062 -1.024 . . . . 0.0 109.246 178.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.976 ' CB ' HG22 ' A' ' 37' ' ' VAL . . . -133.98 -176.84 4.31 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.062 -1.023 . . . . 0.0 111.349 -177.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.614 ' HG2' HD12 ' A' ' 47' ' ' LEU . 2.2 ptm -149.87 153.3 36.48 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.534 ' C ' HD23 ' A' ' 62' ' ' LEU . . . -129.67 -163.31 1.29 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.146 -0.971 . . . . 0.0 109.883 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.002 HD11 HD11 ' B' ' 62' ' ' LEU . 0.4 OUTLIER -172.52 61.75 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.07 -33.28 3.09 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 107.68 -2.168 . . . . 0.0 107.68 -176.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.799 ' HA ' HD12 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -99.15 -20.9 16.41 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.683 -0.892 . . . . 0.0 109.653 177.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.38 -47.48 82.62 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 178.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.85 -35.0 79.45 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.347 -1.09 . . . . 0.0 109.295 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.836 HD11 ' CB ' ' A' ' 10' ' ' LYS . 75.3 mt -63.75 -23.58 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.497 -0.752 . . . . 0.0 109.69 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CZ ' ' CD1' ' A' ' 64' ' ' PHE . 24.2 m-85 -90.72 -21.51 21.56 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.276 -0.89 . . . . 0.0 110.28 178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.42 ' O ' ' N ' ' A' ' 71' ' ' SER . 17.3 t-20 -51.49 -55.06 21.02 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 110.524 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.54 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 110.288 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.42 ' N ' ' O ' ' A' ' 69' ' ' ASN . 78.8 p -151.64 91.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.328 -0.857 . . . . 0.0 110.308 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.01 -20.92 60.36 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 110.401 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.238 -0.914 . . . . 0.0 110.312 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.503 ' HB2' ' CD1' ' A' ' 105' ' ' TYR . 29.5 Cg_endo -67.52 96.21 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 O-C-N 123.651 1.343 . . . . 0.0 110.368 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.94 -43.14 68.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 110.541 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 90' ' ' PHE . . . -162.57 162.42 27.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.133 -0.98 . . . . 0.0 110.758 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.503 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.7 OUTLIER -92.38 169.46 10.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.091 179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CE1' ' HB ' ' A' ' 103' ' ' ILE . 30.2 p-80 -147.69 158.67 44.12 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.108 -0.995 . . . . 0.0 111.001 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -150.8 88.47 1.48 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.429 -0.794 . . . . 0.0 109.779 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.768 ' O ' HG23 ' A' ' 81' ' ' THR . 1.6 mp -128.08 92.45 3.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.943 -1.098 . . . . 0.0 111.054 -177.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -164.29 -170.44 2.08 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.297 -0.877 . . . . 0.0 110.297 179.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.42 -24.07 6.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.12 -95.26 0.65 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.84 -164.47 1.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -1.136 . . . . 0.0 110.111 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HB2' ' OG1' ' A' ' 81' ' ' THR . 14.9 mmtt 60.91 -127.15 0.92 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.184 -0.947 . . . . 0.0 109.497 178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.58 -151.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.525 -1.36 . . . . 0.0 110.58 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.645 ' CE ' HD23 ' A' ' 80' ' ' LEU . 9.0 tpt -132.24 44.37 2.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 110.105 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.79 166.43 29.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.26 -0.9 . . . . 0.0 110.321 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.757 HD11 HD21 ' A' ' 80' ' ' LEU . 4.9 mt -128.8 144.15 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.83 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 76' ' ' ALA . 2.1 t80 -121.95 143.56 49.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.18 -0.95 . . . . 0.0 110.705 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 1.056 HG21 HD11 ' A' ' 95' ' ' ILE . 60.4 m -115.53 99.34 7.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 110.238 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.465 HD13 ' N ' ' A' ' 92' ' ' ILE . 0.1 OUTLIER -69.59 -5.97 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.247 -0.908 . . . . 0.0 110.978 -179.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.523 ' O ' HG22 ' A' ' 91' ' ' THR . 52.5 mttt -111.76 138.81 21.69 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.845 -1.16 . . . . 0.0 110.296 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -51.54 143.88 34.59 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.567 1.298 . . . . 0.0 110.708 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 1.056 HD11 HG21 ' A' ' 91' ' ' THR . 47.7 mm -90.37 156.03 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.298 -0.876 . . . . 0.0 110.108 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 97' ' ' ILE . . . -122.35 47.41 1.93 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.942 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 96' ' ' ALA . 18.8 tt 39.48 34.78 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-O 121.411 0.624 . . . . 0.0 111.775 178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.82 43.25 0.02 OUTLIER Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' N ' ' A' ' 100' ' ' GLU . 28.1 tt0 -106.23 167.83 9.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.396 -1.061 . . . . 0.0 110.055 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HB3' ' CE1' ' A' ' 19' ' ' PHE . 13.1 pt-20 -98.09 151.86 19.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.157 -0.965 . . . . 0.0 110.447 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 ' HB2' ' A' ' 20' ' ' ALA . 57.5 mt -126.94 154.31 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.22 -0.925 . . . . 0.0 110.719 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.546 ' C ' HG23 ' A' ' 103' ' ' ILE . 68.6 p -137.92 -145.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.546 HG23 ' C ' ' A' ' 102' ' ' THR . 1.1 pt -154.1 -165.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.949 -1.094 . . . . 0.0 110.979 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.58 107.92 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.549 -0.72 . . . . 0.0 110.649 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.503 ' CD1' ' HB2' ' A' ' 74' ' ' PRO . 13.6 t80 -160.99 67.86 0.32 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.376 -0.827 . . . . 0.0 109.992 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 59.02 -129.44 49.62 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.418 ' OD1' ' CD2' ' A' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.33 0.23 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.216 -1.167 . . . . 0.0 110.316 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 t0 51.57 68.71 0.76 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.203 -0.936 . . . . 0.0 110.522 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.418 ' CD2' ' OD1' ' A' ' 107' ' ' ASP . 24.0 m-85 -59.13 107.8 0.6 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 110.308 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.01 173.01 3.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.923 . . . . 0.0 110.505 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.729 HD23 ' N ' ' A' ' 111' ' ' LEU . 1.8 pt? -152.82 -162.01 1.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 110.387 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.2 p -174.3 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 110.545 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.44 85.28 0.19 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.2 -0.938 . . . . 0.0 110.301 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -62.17 147.43 95.06 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.674 1.355 . . . . 0.0 110.429 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.69 1.43 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.236 -0.915 . . . . 0.0 110.56 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.803 HD12 ' HB3' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -75.12 76.65 2.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 110.222 179.453 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 119' ' ' ASN . 41.3 p -58.52 87.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.271 -0.893 . . . . 0.0 110.492 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . 0.407 ' N ' ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER 57.64 -83.57 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.447 -0.783 . . . . 0.0 110.642 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' A' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 117.979 -1.01 . . . . 0.0 110.332 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.4 ptp . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.198 0.523 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -167.25 139.37 3.3 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.0 110.332 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -140.91 146.99 38.16 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -0.927 . . . . 0.0 110.334 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -48.3 -27.68 2.66 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.302 -0.874 . . . . 0.0 110.79 -179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.488 ' O ' HG13 ' B' ' 6' ' ' VAL . 96.5 mtt180 -68.47 -51.9 38.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 110.119 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.625 HG21 HG13 ' B' ' 30' ' ' VAL . 17.4 m -155.24 151.02 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.361 -0.837 . . . . 0.0 110.228 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ILE . . . . . 0.592 ' C ' HD13 ' B' ' 7' ' ' ILE . 0.0 OUTLIER -96.97 121.0 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.914 . . . . 0.0 109.775 179.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' VAL . . . . . 0.537 ' N ' HD13 ' B' ' 7' ' ' ILE . 97.5 t -91.71 138.02 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.24 -0.913 . . . . 0.0 110.673 -179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.47 90.91 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 110.094 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.829 ' CB ' HD11 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -109.93 -21.07 12.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.384 -0.823 . . . . 0.0 110.494 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.679 ' O ' HD23 ' B' ' 13' ' ' LEU . 2.5 m -76.98 132.26 71.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 110.393 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -51.82 131.31 37.59 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.455 1.239 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.779 ' O ' HD12 ' B' ' 13' ' ' LEU . 3.3 pp -175.4 33.18 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.351 -0.843 . . . . 0.0 110.21 177.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.16 50.78 20.89 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . 162.76 113.74 0.3 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -123.21 124.62 43.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -1.121 . . . . 0.0 110.121 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.621 ' CA ' HG23 ' B' ' 67' ' ' ILE . . . 162.9 171.07 28.67 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.755 HG13 ' HB ' ' B' ' 101' ' ' ILE . 2.1 p -110.76 107.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.077 -1.249 . . . . 0.0 109.229 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.495 ' CE1' ' HB3' ' B' ' 100' ' ' GLU . 1.7 m-85 -87.05 159.05 19.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 111.837 -176.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 1.078 ' HB2' HD11 ' B' ' 101' ' ' ILE . . . -124.95 133.62 52.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.642 -0.661 . . . . 0.0 110.028 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.26 70.21 0.71 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.25 -0.906 . . . . 0.0 110.497 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LYS . . . . . 0.444 ' N ' ' HA ' ' B' ' 97' ' ' ILE . 15.3 ptmt -173.44 89.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.166 -0.959 . . . . 0.0 110.551 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.451 ' O ' ' CG ' ' B' ' 24' ' ' PHE . 26.6 p -51.33 145.84 7.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.131 -0.98 . . . . 0.0 110.776 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PHE . . . . . 0.451 ' CG ' ' O ' ' B' ' 23' ' ' SER . 1.6 m-85 -170.34 177.69 4.02 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.0 110.219 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.43 167.86 11.96 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 110.206 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' B' ' 92' ' ' ILE . 0.1 OUTLIER -53.37 106.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 110.436 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 141.58 42.33 0.07 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 -178.23 4.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.193 -1.181 . . . . 0.0 110.235 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LEU . . . . . 0.819 ' HB3' HD12 ' B' ' 116' ' ' LEU . 2.9 tt -140.73 126.43 19.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.208 -0.932 . . . . 0.0 110.69 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.674 ' N ' HD23 ' B' ' 29' ' ' LEU . 39.6 t -114.4 168.63 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.803 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLU . . . . . 0.505 ' HA ' HD12 ' B' ' 89' ' ' ILE . 0.1 OUTLIER -136.87 150.22 48.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.004 -1.06 . . . . 0.0 110.859 -179.438 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -165.56 -161.9 0.55 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.372 -0.83 . . . . 0.0 110.076 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.474 ' C ' HD12 ' B' ' 34' ' ' LEU . 0.1 OUTLIER -174.83 57.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.077 -1.014 . . . . 0.0 110.626 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.474 HD12 ' C ' ' B' ' 33' ' ' CYS . 0.6 OUTLIER -150.88 51.7 0.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.177 -0.952 . . . . 0.0 110.511 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.27 143.37 28.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 111.001 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.956 HD11 HD22 ' A' ' 62' ' ' LEU 0.27 96.4 mt -132.42 89.39 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' VAL . . . . . 0.957 HG22 ' CB ' ' B' ' 59' ' ' ALA . 61.5 t -109.23 147.65 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 121.668 0.747 . . . . 0.0 112.853 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.563 ' HB2' ' CD1' ' B' ' 43' ' ' TRP . 25.2 mmm180 -150.37 -160.24 1.14 Allowed 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 175.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -148.06 88.99 1.7 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 0.0 110.676 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -177.87 156.99 1.13 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.186 -0.946 . . . . 0.0 110.6 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.67 -46.07 63.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.246 -0.909 . . . . 0.0 109.862 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -51.07 -24.75 4.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.926 . . . . 0.0 109.554 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.899 ' CE2' HD13 ' B' ' 47' ' ' LEU . 0.8 OUTLIER -63.13 -60.97 2.7 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.568 -0.707 . . . . 0.0 109.785 178.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' GLY . . . . . . . . . . . . . . . -47.62 -28.71 5.26 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' THR . . . . . . . . . . . . . 1.7 m -90.59 -20.63 22.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -1.125 . . . . 0.0 110.419 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' B' ' 43' ' ' TRP . . . -92.47 -47.78 6.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.303 -0.873 . . . . 0.0 111.351 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.899 HD13 ' CE2' ' B' ' 43' ' ' TRP . 0.5 OUTLIER -86.92 21.4 2.29 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.112 -0.992 . . . . 0.0 111.551 -177.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . 0.587 ' HA ' HD21 ' B' ' 51' ' ' LEU . 0.6 OUTLIER -44.13 92.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.387 -0.82 . . . . 0.0 111.973 -178.33 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' B' ' 47' ' ' LEU . 1.3 m-20 -149.39 -107.72 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' B' ' 50' ' ' TYR . 12.5 m-85 -104.33 65.75 0.79 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.327 -1.483 . . . . 0.0 107.414 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.632 ' H ' HD22 ' B' ' 51' ' ' LEU . 0.4 OUTLIER -56.21 140.9 43.02 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 122.024 0.916 . . . . 0.0 112.442 -174.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -143.04 94.58 2.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' SER . . . . . . . . . . . . . 16.9 t -119.89 153.67 35.51 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.068 -1.02 . . . . 0.0 111.196 -176.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ARG . . . . . 0.445 ' O ' ' N ' ' B' ' 56' ' ' ASN . 0.0 OUTLIER -143.22 109.8 5.46 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.438 -0.789 . . . . 0.0 109.927 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' B' ' 54' ' ' ARG . 0.4 OUTLIER 60.37 -76.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.828 -0.545 . . . . 0.0 111.054 -179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 54' ' ' ARG . 15.3 p-10 -116.89 -32.67 5.02 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.842 -1.161 . . . . 0.0 110.824 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' MET . . . . . . . . . . . . . 27.3 mmm -63.98 125.2 23.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.174 -0.954 . . . . 0.0 110.786 -179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' SER . . . . . 0.448 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 10.6 m -126.08 105.72 9.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.062 -1.023 . . . . 0.0 109.386 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ALA . . . . . 0.957 ' CB ' HG22 ' B' ' 37' ' ' VAL . . . -134.04 -176.77 4.29 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.035 -1.041 . . . . 0.0 111.455 -177.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' MET . . . . . 0.628 ' HG2' HD12 ' B' ' 47' ' ' LEU . 2.2 ptm -150.11 153.49 36.48 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.726 -0.609 . . . . 0.0 109.448 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ALA . . . . . 0.542 ' C ' HD23 ' B' ' 62' ' ' LEU . . . -129.77 -163.27 1.28 Allowed 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.218 -0.926 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 1.002 HD11 HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -172.54 61.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.12 -33.31 3.07 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' B' ' 67' ' ' ILE . 0.1 OUTLIER -99.11 -20.92 16.42 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.664 -0.904 . . . . 0.0 109.7 177.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . -56.46 -47.41 83.6 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.91 -34.9 79.18 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.379 -1.071 . . . . 0.0 109.243 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.829 HD11 ' CB ' ' B' ' 10' ' ' LYS . 75.4 mt -63.98 -23.3 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.499 -0.751 . . . . 0.0 109.704 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . 0.535 ' CZ ' ' CD1' ' B' ' 64' ' ' PHE . 24.2 m-85 -90.95 -21.46 21.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 110.151 178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASN . . . . . 0.418 ' O ' ' N ' ' B' ' 71' ' ' SER . 17.4 t-20 -51.54 -55.0 21.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.535 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -63.59 81.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.224 -0.923 . . . . 0.0 110.287 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' SER . . . . . 0.418 ' N ' ' O ' ' B' ' 69' ' ' ASN . 78.8 p -151.67 90.98 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.96 -20.96 60.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 0.0 110.428 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.08 165.88 17.3 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 110.32 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' B' ' 105' ' ' TYR . 29.6 Cg_endo -67.53 96.23 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.675 1.355 . . . . 0.0 110.367 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -70.86 -43.22 68.92 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.217 -0.927 . . . . 0.0 110.58 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 90' ' ' PHE . . . -162.55 162.47 27.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.162 -0.961 . . . . 0.0 110.762 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ARG . . . . . 0.511 ' O ' HG23 ' B' ' 89' ' ' ILE . 0.7 OUTLIER -92.4 169.57 10.46 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -0.877 . . . . 0.0 110.087 179.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . 0.486 ' CE1' ' HB ' ' B' ' 103' ' ' ILE . 30.0 p-80 -147.76 158.86 44.22 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 110.94 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -151.07 88.53 1.46 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.445 -0.785 . . . . 0.0 109.79 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' LEU . . . . . 0.772 HD21 HD11 ' B' ' 89' ' ' ILE . 1.6 mp -128.18 92.42 3.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.982 -1.074 . . . . 0.0 111.037 -177.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' THR . . . . . 0.771 HG23 ' O ' ' B' ' 80' ' ' LEU . 0.8 OUTLIER -164.28 -170.44 2.08 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.33 -0.856 . . . . 0.0 110.281 179.037 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ALA . . . . . . . . . . . . . . . -118.44 -24.11 6.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.2 -0.937 . . . . 0.0 110.487 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.04 -95.25 0.65 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.7 mt -89.99 -164.27 1.13 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.234 -1.156 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LYS . . . . . 0.401 ' HB2' ' OG1' ' B' ' 81' ' ' THR . 15.1 mmtt 60.78 -127.25 0.94 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.188 -0.945 . . . . 0.0 109.448 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.48 -151.75 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.449 -1.407 . . . . 0.0 110.608 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' MET . . . . . 0.649 ' CE ' HD23 ' B' ' 80' ' ' LEU . 9.0 tpt -132.26 44.49 2.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.879 . . . . 0.0 110.085 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 27.8 mtt85 -149.99 166.31 30.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.226 -0.921 . . . . 0.0 110.212 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.772 HD11 HD21 ' B' ' 80' ' ' LEU . 4.9 mt -128.73 144.18 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -0.924 . . . . 0.0 109.859 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' PHE . . . . . 0.515 ' O ' ' HB1' ' B' ' 76' ' ' ALA . 2.1 t80 -121.98 143.53 49.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 110.689 -179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 1.082 HG21 HD11 ' B' ' 95' ' ' ILE . 60.0 m -115.54 99.32 7.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 0.0 110.297 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.476 HD13 ' N ' ' B' ' 92' ' ' ILE . 0.1 OUTLIER -69.55 -5.99 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 121.259 -0.901 . . . . 0.0 110.946 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LYS . . . . . 0.538 ' O ' HG22 ' B' ' 91' ' ' THR . 52.5 mttt -111.74 138.75 21.66 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.752 -1.218 . . . . 0.0 110.283 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -51.68 143.94 35.69 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 O-C-N 123.559 1.294 . . . . 0.0 110.718 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . 1.082 HD11 HG21 ' B' ' 91' ' ' THR . 47.7 mm -90.31 156.04 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.159 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ALA . . . . . 0.612 ' O ' HG22 ' B' ' 97' ' ' ILE . . . -122.34 47.35 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.164 -0.96 . . . . 0.0 110.917 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' ILE . . . . . 0.612 HG22 ' O ' ' B' ' 96' ' ' ALA . 18.9 tt 39.49 34.71 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 CA-C-O 121.368 0.604 . . . . 0.0 111.795 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . . . . . . . . . . . 153.87 43.26 0.02 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.402 ' CG ' ' N ' ' B' ' 100' ' ' GLU . 28.1 tt0 -106.27 167.88 9.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -1.102 . . . . 0.0 109.992 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' GLU . . . . . 0.495 ' HB3' ' CE1' ' B' ' 19' ' ' PHE . 13.1 pt-20 -98.13 151.7 20.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 110.438 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ILE . . . . . 1.078 HD11 ' HB2' ' B' ' 20' ' ' ALA . 57.6 mt -126.59 154.51 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.29 -0.881 . . . . 0.0 110.942 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' THR . . . . . 0.547 ' C ' HG23 ' B' ' 103' ' ' ILE . 69.2 p -137.99 -145.36 0.2 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.762 -0.587 . . . . 0.0 109.523 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' ILE . . . . . 0.547 HG23 ' C ' ' B' ' 102' ' ' THR . 1.1 pt -154.11 -165.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.987 -1.07 . . . . 0.0 110.994 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' SER . . . . . . . . . . . . . 1.2 t 56.55 107.95 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.475 -0.765 . . . . 0.0 110.65 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' B' ' 74' ' ' PRO . 13.7 t80 -161.01 67.9 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.848 . . . . 0.0 110.012 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLY . . . . . . . . . . . . . . . 58.99 -129.43 49.65 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . 0.409 ' OD1' ' CD2' ' B' ' 109' ' ' TYR . 9.3 t70 -148.79 -65.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -1.116 . . . . 0.0 110.319 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 17.1 t0 51.61 68.65 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 110.558 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.409 ' CD2' ' OD1' ' B' ' 107' ' ' ASP . 24.2 m-85 -59.2 107.91 0.62 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.302 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.05 173.07 3.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.208 -0.932 . . . . 0.0 110.466 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . 0.734 HD23 ' N ' ' B' ' 111' ' ' LEU . 1.8 pt? -152.92 -162.11 1.42 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.293 -0.879 . . . . 0.0 110.312 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' SER . . . . . . . . . . . . . 2.4 p -174.24 31.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 110.565 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.39 85.3 0.19 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 0.0 110.27 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -62.2 147.36 95.16 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.628 1.33 . . . . 0.0 110.472 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ARG . . . . . . . . . . . . . 10.2 mtm-85 -135.71 71.77 1.43 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 110.492 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.819 HD12 ' HB3' ' B' ' 29' ' ' LEU . 0.3 OUTLIER -75.22 76.75 2.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 110.181 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' THR . . . . . 0.44 ' O ' ' N ' ' B' ' 119' ' ' ASN . 41.3 p -58.57 87.76 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -0.857 . . . . 0.0 110.444 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' B' ' 116' ' ' LEU . 0.7 OUTLIER 57.77 -83.66 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.502 -0.749 . . . . 0.0 110.627 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ASN . . . . . 0.44 ' N ' ' O ' ' B' ' 117' ' ' THR . 13.6 p-10 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.295 179.96 . . . . . . . . 1 1 . 1 stop_ save_